Oligonucleotides Containing Abasic Site Analogues
(m, 15H). 13C NMR (CDCl3) δ 155.1, 134.1, 116.8, 98.7, 79.5,
72.3, 63.2, 49.0, 36.9, 28.2, 28.0, 19.8. IR (KBr) 3369, 2994, 2947,
2872, 1747, 1719, 1688, 1528, 1459, 1438, 1390, 1367, 1299, 1201,
1167, 1080, 1043, 833 cm-1. FAB-HRMS (M + H+) calcd for
C14H26O6N 304.1760, found 304.1743.
(3:1 hexanes/ethyl acetate) to yield 15 (2.33 g, 7.53 mmol, 98%).
1H NMR (CDCl3) δ 7.38 (m, 10H), 4.58 (m, 4H), 4.20 (m, 1H),
3.61 (dd, 1H, J) 9, 5 Hz), 3.53 (dd, 1H, J ) 9, 3 Hz), 2.63 (m,
3H), 2.35 (dd, 1H, J ) 5, 1 Hz), 2.20 (dd, 1H, J ) 5, 1 Hz). 13C
NMR (CDCl3) δ 215.4 137.7(9), 137.7(5), 128.1(0), 128.0(8),
127.3(9), 127.3(4), 127.3(0), 127.2, 77.7, 72.8, 70.9, 70.1, 44.0,
42.0, 39.6. IR (KBr) 3064, 3030, 2857, 1740, 1497, 1454, 1365,
1199, 1168, 1146, 1121, 1028 cm-1. FAB-HRMS (M + H+) calcd
for C20H23O3 311.1647, found 311.1636.
Compound 16. TiCl4 (7.53 mmol, 7.53 mL, 1 M in methylene
chloride) was added dropwise to a suspension of Nysted’s reagent
in THF (17.17 g, 7.53 mmol, 20 wt % in THF) at 0 °C. Additional
THF (20 mL) was added to facilitate stirring. The suspension was
kept at 0 °C for 10 min before neat 15 (2.33 g, 7.53 mmol) was
added. The reaction was warmed to room temperature and stirred
overnight. Saturated sodium bicarbonate solution (5 mL) was added
to quench the reaction. The suspension was diluted with ethyl
acetate (50 mL) and filtered. Water (20 mL) was added to the
filtrate. The organic layer was separated, washed with brine, and
dried over magnesium sulfate. The solvent was removed in vacuo
and the crude product was purified by column chromatography (10:1
hexanes/ethyl acetate) to yield the olefination product of 15 (1.28
g, 4.15 mmol, 55%). 1H NMR (CDCl3) δ 7.35 (m, 10H), 4.92 (m,
2H), 4.54 (m, 4H), 3.90 (dd, 1H, J ) 12, 6 Hz), 3.35 (dd, 1H, J )
10, 1.5 Hz), 3.43 (dd, J ) 10, 1.5 Hz), 2.68 (m, 2H), 2.45 (m, 2H),
2.20 (dd, 1H, J ) 16, 6 Hz). 13C NMR (CDCl3) δ 148.2, 138.7,
138.5, 128.2(8), 128.2(6), 127.5(9), 127.4(6), 127.4(3), 127.4(0),
107.1, 80.9, 73.0, 71.4, 71.1, 45.2, 38.6, 34.0. IR (KBr) 3064, 3028,
2983, 2940, 2854, 1658, 1496, 1454, 1364, 1205, 1099, 1028, 878,
751, 697 cm-1. FAB-HRMS (MH+) calcd for C25H21O2 309.1855,
found 309.1851.
Compound 9. Compound 8 (400 mg, 1.3 mmol) was treated
with TFA/CH2Cl2 (1:1, 10 mL) at room temperature for 30 min.
The volatile fraction was removed in vacuo. A 3% solution of TFA
in methanol (10 mL) was added, and the reaction was stirred at
room temperature overnight. The solvent was removed in vacuo.
The residue was dissolved in methanol (10 mL). Potassium
carbonate (538 mg, 3.9 mmol) was added, and the reaction was
stirred at room temperature for 3 h. The reaction was diluted with
methanol (10 mL) and centrifuged. The supernatant was saved, and
the solid was washed with CH2Cl2/MeOH (1:1, 2 × 5 mL). The
combined supernatant was concentrated and purified by column
chromatography (1:3 methanol/CH2Cl2) to yield 9 (167 mg, 1.27
1
mmol, 97%). H NMR (d4-MeOH) δ 4.32 (m, 1H), 3.59 (m, 2H),
3.51 (m, 1H), 2.74 (dd, 2H, J ) 17, 7 Hz), 2.18 (dd, 2H, J) 17,
3 Hz). 13C NMR (d4-MeOH) δ 177.6, 68.6, 65.3, 62.1, 39.6. IR
(KBr) 3300 (br), 2928, 1696, 1445, 1270, 1084, 713 cm-1. FAB-
HRMS (M + H+) calcd for C5H10O3N 132.0661, found 132.0661.
Compound 10. Pyridine (5 mL) was added to a mixture of 9
(150 mg, 1.15 mmol) and dimethoxytrityl chloride (507 mg, 1.50
mmol). The reaction was stirred at room temperature for 12 h before
quenching with methanol (1 mL). The solvent was removed and
the crude product was purified by column chromatography (1:20
methanol/ethyl acetate) to yield 10 (500 mg, 1.15 mmol, 100%).
1H NMR (CDCl3) δ 7.42 (d, 2H, J ) 8 Hz), 7.19-7.31 (m, 7H),
6.80 (m, 5H), 4.19 (s, br 1H), 3.94 (b, 1H), 3.75 (m, 6H), 3.69 (b,
1H), 3.24 (m, 1H), 3.09 (m, 1H), 2.70 (dd, 1H, J ) 17, 7 Hz), 2.28
(dd, J ) 17, 3 Hz). 13C NMR (CDCl3) δ 176.68, 158.57, 158.54,
144.49, 135.70, 135.54, 130.06, 129.95, 128.06, 127.96, 126.95,
113.27, 86.50, 69.85, 64.44, 63.53, 55.20, 40.10. IR (KBr) 3398
(br), 2957, 2834, 1696, 1607, 1577, 1508, 1449, 1301, 1250, 1178,
1089, 1034, 910, 831, 731, 700 cm-1. ESI-HRMS (M + Na+) calcd
for C26H27NO5Na 456.1787, found 456.1789.
A solution of N-methylmorphine N-oxide (305 mg, 2.6 mmol)
and osmium tetraoxide (17 mg, 0.065 mmol) in a mixture of
t-BuOH/H2O (1:1, 12 mL) was added to the above olefination
product (400 mg, 1.3 mmol) at 0 °C. The reaction was warmed to
room temperature and stirred for 24 h. Sodium bisulfite (1.5 g)
was added, and the suspension was stirred for 30 min. The mixture
was diluted with methylene chloride (30 mL) and water (10 mL).
The aqueous layer was extracted with methylene chloride (3 × 30
mL). The organic layers were combined and dried over magnesium
sulfate. The solvent was evaporated, and the crude product was
purified by column chromatography (1:4 hexanes/ethyl acetate) to
give the dihydroxylation product (380 mg, 1.11 mmol, 85%) as a
mixture of stereoisomers. 1H NMR (CDCl3) δ 7.32 (m, 10H), 4.52
(m, 4H), 4.12 and 3.98 (1H), 3.52-3.31 (m, 5H), 2.70 and 2.36
(2H), 2.19-2.02 (m, 2H), 1.83 and 1.75 (1H), 1.61 and 1.46 (1H).
13C NMR (CDCl3) δ 138.4, 138.2, 138.0, 137.6, 128.4(0), 128.2-
(9), 128.2(6), 127.7(5), 127.6(7), 127.5(8), 127.5(6), 127.5(3),
127.4(9), 127.4(7), 127.4(0), 82.7, 82.3, 81.6, 80.3, 73.3, 72.9, 72.1,
Compound 11. TMSCl (1.32 mmol, 145 mg, 169 µL) was added
to a solution of 10 (1 mmol, 440 mg) and triethylamine (2.64 mmol,
167 mg, 154 µL) in THF (10 mL) at 0 °C. The reaction was warmed
to room temperature and stirred for 2 h. Triethylamine (20 mmol,
2.02 g, 2.8 mL) was added, followed by acetyl bromide (10 mmol,
12.30 g, 0.75 mL). The reaction was continued at room temperature
for 2 h. Triethylamine trihydrofluoride (1 mmol, 161 mg, 16 µL)
and methanol (5 mL) were added, and the reaction was stirred at
room temperature for 15 min. The mixture was diluted with
methylene chloride (100 mL) and washed with saturated sodium
bicarbonate solution, followed by brine. The organic layer was dried
over magnesium sulfate. The solvent was removed, and the crude
product was purified by column chromatography (1:2 hexanes/ethyl
acetate) to give 11 (255 mg, 0.52 mmol, 52%). 1H NMR (CDCl3)
δ 7.22 (m, 10H), 6.82 (m, 4H), 4.30 (m, 2H), 3.78 (s, 6H), 3.49
(dd, 1H, J) 10, 4 Hz), 3.32 (dd, 1H, J ) 10, 2 Hz), 3.17 (dd, 1H,
J ) 18, 6 Hz), 2.52 (m, 3H), 2.49 (m, 1H), 1.81 (br, 1H). 13C
NMR (CDCl3) δ 174.3, 171.0, 158.6, 144.3, 135.6, 135.4, 129.9-
(1), 129.8(7), 127.9(6), 127.9(3), 127.0, 113.3, 86.8, 77.2, 67.3,
65.9, 61.9, 55.2, 42.9, 29.7, 25.2. IR (KBr), 3503(br), 2959, 2929,
2837, 1745, 1700, 1608, 1509, 1465, 1444, 1370, 1302, 1251, 1208,
1078, 1036, 834 cm-1. ESI-HRMS (M + Na+) calcd for C28H29-
NO6Na 498.1893, found 498.1895.
Compound 15. A solution of 1437 (2.4 g, 7.7 mmol) and Dess-
Martin periodane (3.27 g, 7.7 mmol) was stirred at room temper-
ature in methylene chloride (70 mL) for 1 h. The reaction was
diluted with diethyl ether (150 mL) and washed with a mixture of
10% sodium thiosulfate (50 mL), followed by saturated sodium
bicarbonate (50 mL). The aqueous layer was back-washed with
diethyl ether (100 mL). The organic layers were combined, washed
with brine, and dried over magnesium sulfate. The solvent was
evaporated, and the crude was purified with column chromatography
71.7, 71.3, 70.7, 69.3, 68.7, 44.6, 44.4, 43.4, 41.4, 38.7, 38.3 cm-1
.
IR (KBr) 3400 (br), 3005, 2932, 2852, 1474, 1397, 1113, 1098,
909, 734, 697 cm-1. FAB-HRMS (M + H+) calcd for C21H27O4
343.1909, found 343.1900.
TBSOTf (1.53 mmol, 404 mg, 351 µL) was added dropwise to
a solution of the above dihydroxylation product (0.51 mmol, 175
mg) and 2,6-lutidine (2.04 mmol, 219 mg, 238 µL) in methylene
chloride (10 mL) at 0 °C. The reaction was warmed to room
temperature, and stirring was continued for 6 h. The mixture was
diluted with ethyl acetate (100 mL) and washed with ammonium
chloride (1 M), followed successively with saturated sodium
bicarbonate and brine. The organic layer was dried over magnesium
sulfate. The solvent was removed in vacuo, and the crude product
was purified by column chromatography (20:1 hexanes/ethyl
acetate) to yield 16 (0.44 mmol, 249 mg, 81%) as a mixture of
1
diastereomers. H NMR (CDCl3) δ 7.34 (m, 10H), 4.58 (m, 4H),
3.98 and 3.72 (1H), 3.62-3.41 (m, 4H), 2.59-2.24 (m, 2H), 2.00
to 1.66 (m, 3H), 0.95 (m, 18H), 0.11 (m, 12H). 13C NMR (CDCl3)
δ 138.9(2), 138.8(4), 138.7(6), 138.6(8), 128.2(6), 128.2(4), 128.2-
(2), 128.2(0), 127.6(3), 127.6(0), 127.5(3), 127.4(6), 127.3(8),
J. Org. Chem, Vol. 73, No. 7, 2008 2701